WASHINGTON (AP) — Drugmaker Pfizer has agreed to lower drug costs under a deal struck with President Donald Trump’s administration. Trump made the announcement Tuesday with Pfizer CEO Albert Bourla at the White House. Under the agreement, New York-based Pfizer will charge most-favored-nation pricing to Medicaid and guarantee the same pricing on newly launched drugs. That involves matching the lowest price offered in other developed nations. The agreement by Pfizfer builds on an executive order Trump signed in May setting a deadline for drugmakers to electively lower prices or face new limits on what the government will pay.
(Copyright 2025 The Associated Press. All Rights Reserved.)